PDF herunterladen
CC BY-NC-ND 4.0 · Neuropediatrics 2022; 53(01): 032-038
DOI: 10.1055/s-0041-1728655
Original Article

Clinical Features and Outcomes of Streptococcus pneumoniae Meningitis in Children: A Retrospective Analysis of 26 Cases in China

Wenhui Wang
1   Department of Neurology, Children's Hospital of Shanxi, Taiyuan, Shanxi, China
,
Hong Han
1   Department of Neurology, Children's Hospital of Shanxi, Taiyuan, Shanxi, China
,
Lijun Du
1   Department of Neurology, Children's Hospital of Shanxi, Taiyuan, Shanxi, China
,
Zhaoyang Li
1   Department of Neurology, Children's Hospital of Shanxi, Taiyuan, Shanxi, China
,
Yunhong Wu
1   Department of Neurology, Children's Hospital of Shanxi, Taiyuan, Shanxi, China
› Institutsangaben Funding None.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background Streptococcus pneumoniae is an important cause of pediatric meningitis.

Objective The aim of this study was to analyze the clinical features and outcomes of children with pneumococcal meningitis at our hospital in China, so as to provide basis for improving the clinical treatment effect.

Methods This retrospective analysis included patients aged <16 years treated for pneumococcal meningitis at the Department of Neurology, Children's Hospital of Shanxi (January 2014–February 2016). Clinical data were extracted from the medical records. Patients were followed up for 6 months after discharge.

Results The analysis included 26 children aged 2 months to 13 years, with 17 (65.4%) aged <3 years. Presenting symptoms included fever (100%), lethargy (100%), impaired consciousness (88.5%), neck stiffness (69.2%), seizures (53.8%), and headache (50.0%). All patients had positive cerebrospinal fluid (CSF) cultures. The final treatment was vancomycin combined with a third-generation cephalosporin or other antibiotics in 25 patients. Eleven patients (42.3%) were recovered, 3 (11.5%) had neurological sequelae, and 12 (46.2%) died. Impaired consciousness (p = 0.035), cerebral hernia (p = 0.037), respiratory failure (p = 0.004), heart failure (p = 0.044), septic shock (p = 0.037), low CSF white blood cell count (p = 0.036), high CSF protein levels (p = 0.028), low white blood cell count (p = 0.036), and low blood neutrophil ratio (p = 0.016) are associated with a poor prognosis to pneumococcal meningitis.

Conclusion Pneumococcal meningitis is associated with a poor prognosis in many children. Poor prognosis might be related to early ineffective antibiotic therapy, a combination of systemic failure, neurological problems, and changed inflammatory response. It is important to rapid initiation of appropriate antibiotic therapy if meningitis is suspected.

Keywords

Streptococcus pneumoniae - meningitis - children - infants - neurological complications

Supplementary Material



Publikationsverlauf

Eingereicht: 13. März 2020

Angenommen: 14. Februar 2021

Artikel online veröffentlicht:
13. Oktober 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010; 10 (01) 32-42
    CrossrefPubMedGoogle Scholar
  • 2 Brouwer MC, van de Beek D. Epidemiology of community-acquired bacterial meningitis. Curr Opin Infect Dis 2018; 31 (01) 78-84
    CrossrefPubMedGoogle Scholar
  • 3 Tunkel AR, Hartman BJ, Kaplan SL. et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39 (09) 1267-1284
    CrossrefPubMedGoogle Scholar
  • 4 Le Saux N. Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age. Paediatr Child Health 2014; 19 (03) 141-152
    CrossrefPubMedGoogle Scholar
  • 5 National Institute for Health and Care Excellence (NICE). Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and management. CG102. Accessed July 9, 2020 at: https://www-nice-org-uk.acces.bibl.ulaval.ca/guidance/cg102/resources/meningitis-bacterial-and-meningococcal-septicaemia-in-under-16s-recognition-diagnosis-and-management-pdf-35109325611205
    PubMedGoogle Scholar
  • 6 Mount HR, Boyle SD. Aseptic and bacterial meningitis: evaluation, treatment, and prevention. Am Fam Physician 2017; 96 (05) 314-322
    PubMedGoogle Scholar
  • 7 Baud O, Aujard Y. Neonatal bacterial meningitis. Handb Clin Neurol 2013; 112: 1109-1113
    CrossrefPubMedGoogle Scholar
  • 8 Jansen AG, Rodenburg GD, van der Ende A. et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009; 49 (02) e23-e29
    CrossrefPubMedGoogle Scholar
  • 9 Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS. Sequelae due to bacterial meningitis among African children: a systematic literature review. BMC Med 2009; 7: 47
    CrossrefPubMedGoogle Scholar
  • 10 Wang CY, Chen YH, Fang C. et al. Antibiotic resistance profiles and multidrug resistance patterns of Streptococcus pneumoniae in pediatrics: a multicenter retrospective study in mainland China. Medicine (Baltimore) 2019; 98 (24) e15942
    CrossrefPubMedGoogle Scholar
  • 11 Jiang H, Huai Y, Chen H. et al. Invasive Streptococcus pneumoniae infection among hospitalized patients in Jingzhou city, China, 2010-2012. PLoS One 2018; 13 (08) e0201312
    CrossrefPubMedGoogle Scholar
  • 12 Jiang H, Su M, Kui L. et al. Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015. PLoS One 2017; 12 (06) e0180161
    CrossrefPubMedGoogle Scholar
  • 13 Su M, Chang L, Zhou W, Mu LY, Kuang LH. Clinical characteristics of children with meningitis caused by Streptococcus pneumoniae and antibiotic resistance of Streptococcus pneumoniae strains. Zhongguo Dang Dai Er Ke Za Zhi 2015; 17 (07) 706-709
    PubMedGoogle Scholar
  • 14 WuXR, LQ. Basic and Clinical Aspects of Pediatric Neurological Diseases. 2nd ed.. Beijing: People's Health Publishing House; 2009: 472-477
    Google Scholar
  • 15 Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1 (7905): 480-484
    CrossrefPubMedGoogle Scholar
  • 16 Hsu MH, Hsu JF, Kuo HC. et al. Neurological complications in young infants with acute bacterial meningitis. Front Neurol 2018; 9: 903
    CrossrefPubMedGoogle Scholar
  • 17 Rumlarová Š, Kosina P, Kračmarová R, Plíšek S, Rejtar P. Pneumococcal meningitis in children. Klin Mikrobiol Infekc Lek 2013; 19 (04) 128-131
    PubMedGoogle Scholar
  • 18 Hua F, Shang S, Yang Y-W. et al. TRIB3 interacts with β-catenin and TCF4 to increase stem cell features of colorectal cancer stem cells and tumorigenesis. Gastroenterology 2019; 156 (03) 708-721.e15
    CrossrefPubMedGoogle Scholar
  • 19 Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996; 22 (01) 100-106
    CrossrefPubMedGoogle Scholar
  • 20 Hénaff F, Levy C, Cohen R. et al; French Group of Pediatric Infectious Diseases (GPIP). Risk factors in children older than 5 years with pneumococcal meningitis: data from a national network. Pediatr Infect Dis J 2017; 36 (05) 457-461
    CrossrefPubMedGoogle Scholar
  • 21 Ivády B, Liptai Z, Ujhelyi E, Balázs G. Pneumococcal meningitis in children--9 1/2-year-experience at Szent László Hospital, Budapest, Hungary. Ideggyogy Sz 2008; 61 (11-12): 385-390
    PubMedGoogle Scholar
  • 22 Tacon CL, Flower O. Diagnosis and management of bacterial meningitis in the paediatric population: a review. Emerg Med Int 2012; 2012: 320309
    CrossrefPubMedGoogle Scholar
  • 23 Berberian G, Pérez MG, Epelbaum C, Ceinos MdelC, Lopardo H, Rosanova MT. Pneumococcal meningitis: a 12 year experience in a children's hospital prior to the universal immunization with a conjugate vaccine. Arch Argent Pediatr 2014; 112 (04) 332-336
    PubMedGoogle Scholar
  • 24 Lucey JM, Gavin P, Cafferkey M, Butler KM. Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007. Ir J Med Sci 2011; 180 (01) 47-50
    CrossrefPubMedGoogle Scholar
  • 25 Jordan I, Calzada Y, Monfort L. et al. Clinical, biochemical and microbiological factors associated with the prognosis of pneumococcal meningitis in children. Enferm Infecc Microbiol Clin 2016; 34 (02) 101-107
    CrossrefPubMedGoogle Scholar
  • 26 van de Beek D, Cabellos C, Dzupova O. et al; ESCMID Study Group for Infections of the Brain (ESGIB). ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 2016; 22 (Suppl. 03) S37-S62
    CrossrefPubMedGoogle Scholar
  • 27 Zhao C, Li Z, Zhang F. et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis 2017; 17 (01) 804
    CrossrefPubMedGoogle Scholar
  • 28 Kosowska-Shick K, McGhee PL, Appelbaum PC. Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae . Antimicrob Agents Chemother 2010; 54 (05) 1670-1677
    CrossrefPubMedGoogle Scholar
  • 29 Klugman KP, Feldman C. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem. Drugs 1999; 58 (01) 1-4
    CrossrefPubMedGoogle Scholar
  • 30 Kim L, McGee L, Tomczyk S, Beall B. Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre- and post-conjugate vaccine eras: a United States perspective. Clin Microbiol Rev 2016; 29 (03) 525-552
    CrossrefPubMedGoogle Scholar
  • 31 Chenoweth CE, Saint S, Martinez F, Lynch III JP, Fendrick AM. Antimicrobial resistance in Streptococcus pneumoniae: implications for patients with community-acquired pneumonia. Mayo Clin Proc 2000; 75 (11) 1161-1168
    CrossrefPubMedGoogle Scholar
  • 32 Hicks LA, Chien YW, Taylor Jr TH, Haber M, Klugman KP. Active Bacterial Core Surveillance (ABCs) Team. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis 2011; 53 (07) 631-639
    CrossrefPubMedGoogle Scholar
  • 33 Austrian R, Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-776
    CrossrefPubMedGoogle Scholar
  • 34 Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med 1974; 134 (03) 505-510
    CrossrefPubMedGoogle Scholar
  • 35 Harboe ZB, Thomsen RW, Riis A. et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009; 6 (05) e1000081
    CrossrefPubMedGoogle Scholar
  • 36 Rückinger S, von Kries R, Siedler A, van der Linden M. Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome. Pediatr Infect Dis J 2009; 28 (02) 118-122
    CrossrefPubMedGoogle Scholar
  • 37 Buchholz G, Koedel U, Pfister HW, Kastenbauer S, Klein M. Dramatic reduction of mortality in pneumococcal meningitis. Crit Care 2016; 20 (01) 312
    CrossrefPubMedGoogle Scholar
  • 38 Erdem H, Elaldi N, Öztoprak N. et al. Mortality indicators in pneumococcal meningitis: therapeutic implications. Int J Infect Dis 2014; 19: 13-19
    CrossrefPubMedGoogle Scholar
  • 39 Antonio M, Dada-Adegbola H, Biney E. et al. Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis 2008; 8: 81
    CrossrefPubMedGoogle Scholar
  • 40 Weinberger DM, Harboe ZB, Sanders EA. et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51 (06) 692-699
    CrossrefPubMedGoogle Scholar